CAMBIANICA, ILARIA NADIA
Distribuzione geografica
| Continente | # |
|---|---|
| NA - Nord America | 457 |
| EU - Europa | 333 |
| AS - Asia | 210 |
| AF - Africa | 23 |
| OC - Oceania | 23 |
| Continente sconosciuto - Info sul continente non disponibili | 9 |
| SA - Sud America | 5 |
| Totale | 1.060 |
| Nazione | # |
|---|---|
| US - Stati Uniti d'America | 447 |
| DE - Germania | 118 |
| IT - Italia | 76 |
| IN - India | 58 |
| CN - Cina | 48 |
| MY - Malesia | 23 |
| AU - Australia | 21 |
| NL - Olanda | 20 |
| FR - Francia | 18 |
| GB - Regno Unito | 16 |
| IR - Iran | 14 |
| UA - Ucraina | 14 |
| IE - Irlanda | 11 |
| JP - Giappone | 10 |
| CA - Canada | 9 |
| CZ - Repubblica Ceca | 9 |
| ES - Italia | 9 |
| TR - Turchia | 8 |
| TW - Taiwan | 8 |
| ZA - Sudafrica | 8 |
| KR - Corea | 7 |
| EU - Europa | 6 |
| RU - Federazione Russa | 6 |
| EG - Egitto | 5 |
| GR - Grecia | 5 |
| HK - Hong Kong | 5 |
| AE - Emirati Arabi Uniti | 4 |
| AT - Austria | 4 |
| NG - Nigeria | 4 |
| PL - Polonia | 4 |
| PT - Portogallo | 4 |
| SA - Arabia Saudita | 4 |
| SG - Singapore | 4 |
| A2 - ???statistics.table.value.countryCode.A2??? | 3 |
| CL - Cile | 3 |
| FI - Finlandia | 3 |
| ID - Indonesia | 3 |
| LK - Sri Lanka | 3 |
| RO - Romania | 3 |
| RS - Serbia | 3 |
| VN - Vietnam | 3 |
| BE - Belgio | 2 |
| BR - Brasile | 2 |
| CI - Costa d'Avorio | 2 |
| DK - Danimarca | 2 |
| IQ - Iraq | 2 |
| NZ - Nuova Zelanda | 2 |
| SE - Svezia | 2 |
| BD - Bangladesh | 1 |
| CH - Svizzera | 1 |
| GH - Ghana | 1 |
| HU - Ungheria | 1 |
| IL - Israele | 1 |
| KG - Kirghizistan | 1 |
| LU - Lussemburgo | 1 |
| MO - Macao, regione amministrativa speciale della Cina | 1 |
| MX - Messico | 1 |
| PK - Pakistan | 1 |
| RE - Reunion | 1 |
| SK - Slovacchia (Repubblica Slovacca) | 1 |
| TG - Togo | 1 |
| TH - Thailandia | 1 |
| TN - Tunisia | 1 |
| Totale | 1.060 |
| Città | # |
|---|---|
| Ann Arbor | 33 |
| Simi Valley | 32 |
| Fairfield | 23 |
| Milan | 22 |
| Mountain View | 22 |
| Frankfurt am Main | 21 |
| Petaling Jaya | 20 |
| Ashburn | 18 |
| Shanghai | 15 |
| Houston | 12 |
| Buffalo | 11 |
| Cambridge | 11 |
| Dublin | 11 |
| Council Bluffs | 9 |
| Santa Cruz | 8 |
| Seattle | 8 |
| Wuhan | 8 |
| Woodbridge | 7 |
| Forest Hill | 6 |
| Hyderabad | 6 |
| Ichalkaranji | 6 |
| Mumbai | 6 |
| New York | 6 |
| Taipei | 6 |
| University Park | 6 |
| Amsterdam | 5 |
| Dallas | 5 |
| Ioánnina | 5 |
| Nürnberg | 5 |
| Redmond | 5 |
| Trieste | 5 |
| Ujjain | 5 |
| Beijing | 4 |
| Bengaluru | 4 |
| Fremont | 4 |
| Kraków | 4 |
| Menlo Park | 4 |
| Wilmington | 4 |
| Boardman | 3 |
| Boston | 3 |
| Cairo | 3 |
| Denton | 3 |
| Guangzhou | 3 |
| Gurgaon | 3 |
| Hangzhou | 3 |
| Jeddah | 3 |
| Konya | 3 |
| Long Beach | 3 |
| Los Angeles | 3 |
| Madrid | 3 |
| Melbourne | 3 |
| Muizenberg | 3 |
| Parsippany | 3 |
| Pescara | 3 |
| Pittsburgh | 3 |
| Port Harcourt | 3 |
| Rajsamand | 3 |
| Rome | 3 |
| Singapore | 3 |
| Sydney | 3 |
| Toronto | 3 |
| Adelaide | 2 |
| Ankara | 2 |
| Bergamo | 2 |
| Bethesda | 2 |
| Cape Town | 2 |
| Carate Brianza | 2 |
| Central | 2 |
| Chandigarh | 2 |
| Chicago | 2 |
| Cleveland | 2 |
| College Station | 2 |
| Colombo | 2 |
| Columbus | 2 |
| Dhubri | 2 |
| Fars | 2 |
| Fuzhou | 2 |
| Groningen | 2 |
| Helsinki | 2 |
| Indore | 2 |
| Jakarta | 2 |
| Kuala Lumpur | 2 |
| London | 2 |
| Matsugaya | 2 |
| Modena | 2 |
| New Haven | 2 |
| Norristown | 2 |
| Ottawa | 2 |
| Paris | 2 |
| Philadelphia | 2 |
| Poggiomarino | 2 |
| Pune | 2 |
| Santiago | 2 |
| Tempe | 2 |
| Trento | 2 |
| Vancouver | 2 |
| Vienna | 2 |
| Vitoria | 2 |
| Abidjan | 1 |
| Aljustrel | 1 |
| Totale | 537 |
| Nome | # |
|---|---|
| Functionalization with TAT-peptide enhances blood-brain barrier crossing in vitro of nanoliposomes carrying a curcumin-derivative to bind amyloid-β peptide, file e39773b1-ce26-35a3-e053-3a05fe0aac26 | 600 |
| In vitro blood brain barrier models as a screening tool for brain targeted nanobased drug delivery systems, file e39773b1-b9fa-35a3-e053-3a05fe0aac26 | 177 |
| ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier, file e39773b9-5f39-35a3-e053-3a05fe0aac26 | 161 |
| Solid Lipid Nanoparticles: a strategy to overcome the blood-brain barrier, file e39773b2-69c4-35a3-e053-3a05fe0aac26 | 129 |
| Solid Lipid Nanoparticles: a strategy to overcome the blood-brain barrier, file e39773b2-69c3-35a3-e053-3a05fe0aac26 | 21 |
| ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier, file e39773b8-53f8-35a3-e053-3a05fe0aac26 | 5 |
| Totale | 1.093 |
| Categoria | # |
|---|---|
| all - tutte | 1.976 |
| article - articoli | 0 |
| book - libri | 0 |
| conference - conferenze | 0 |
| curatela - curatele | 0 |
| other - altro | 0 |
| patent - brevetti | 0 |
| selected - selezionate | 0 |
| volume - volumi | 0 |
| Totale | 1.976 |
| Totale | Lug | Ago | Sett | Ott | Nov | Dic | Gen | Feb | Mar | Apr | Mag | Giu | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018/2019 | 69 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14 | 55 |
| 2019/2020 | 130 | 24 | 9 | 13 | 9 | 7 | 8 | 15 | 9 | 5 | 8 | 18 | 5 |
| 2020/2021 | 77 | 5 | 9 | 6 | 7 | 12 | 13 | 7 | 2 | 5 | 3 | 3 | 5 |
| 2021/2022 | 60 | 2 | 5 | 2 | 3 | 6 | 6 | 3 | 4 | 7 | 2 | 13 | 7 |
| 2022/2023 | 136 | 5 | 20 | 21 | 8 | 7 | 10 | 6 | 10 | 17 | 5 | 18 | 9 |
| 2023/2024 | 229 | 12 | 20 | 27 | 29 | 18 | 27 | 18 | 12 | 25 | 31 | 10 | 0 |
| Totale | 1.093 | ||||||||||||